258 related articles for article (PubMed ID: 12070358)
1. Barriers to Alzheimer disease drug discovery and development in academia.
Van Eldik LJ; Koppal T; Watterson DM
Alzheimer Dis Assoc Disord; 2002; 16 Suppl 1():S18-28. PubMed ID: 12070358
[TBL] [Abstract][Full Text] [Related]
2. Barriers to Alzheimer disease drug discovery and development in the biotechnology industry.
Altstiel LD
Alzheimer Dis Assoc Disord; 2002; 16 Suppl 1():S29-32. PubMed ID: 12070359
[TBL] [Abstract][Full Text] [Related]
3. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia].
Iida K; Yano T; Ikemori M; Ishida T; Nishimura N
Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438
[TBL] [Abstract][Full Text] [Related]
4. Partnership between academia and industry for drug discovery in Alzheimer's disease.
Ivinson AJ; Lane R; May PC; Hosford DA; Carrillo MC; Siemers ER
Alzheimers Dement; 2008 Mar; 4(2):80-8. PubMed ID: 18631952
[TBL] [Abstract][Full Text] [Related]
5. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
Hafner J
J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
[TBL] [Abstract][Full Text] [Related]
6. The connection between academia and industry.
Singh A; Singh S
Mens Sana Monogr; 2005 Mar; 3(1):5-35. PubMed ID: 22679346
[TBL] [Abstract][Full Text] [Related]
7. Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required.
Brewer GJ
J Investig Med; 2006 Sep; 54(6):291-302. PubMed ID: 17191351
[No Abstract] [Full Text] [Related]
8. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
[TBL] [Abstract][Full Text] [Related]
9. Barriers to Alzheimer disease drug discovery and drug development in the pharmaceutical industry.
Anand R
Alzheimer Dis Assoc Disord; 2002; 16 Suppl 1():S33-9. PubMed ID: 12070360
[TBL] [Abstract][Full Text] [Related]
10. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
Chung TD
Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
[TBL] [Abstract][Full Text] [Related]
11. Drug discovery in academia.
Verkman AS
Am J Physiol Cell Physiol; 2004 Mar; 286(3):C465-74. PubMed ID: 14761879
[TBL] [Abstract][Full Text] [Related]
12. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
[TBL] [Abstract][Full Text] [Related]
13. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
[TBL] [Abstract][Full Text] [Related]
14. The role of modern biology and medicine in drug development in academia and industry.
Blake CA; Barker KL; Sobel BE
Exp Biol Med (Maywood); 2006 Dec; 231(11):1680-1. PubMed ID: 17138752
[TBL] [Abstract][Full Text] [Related]
15. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
16. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
D'Hooghe T
Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
[TBL] [Abstract][Full Text] [Related]
17. The changing environment of graduate and postdoctoral training in drug metabolism: viewpoints from academia, industry, and government.
Stevens JC; Dean DC; Preusch PC; Correia MA
Drug Metab Dispos; 2003 Apr; 31(4):360-6. PubMed ID: 12642460
[TBL] [Abstract][Full Text] [Related]
18. Challenges faced by the pharmaceutical industry: training graduates for employment in pharmaceutical R&D.
Mooney KG
Eur J Pharm Sci; 2001 Feb; 12(4):353-9. PubMed ID: 11231101
[TBL] [Abstract][Full Text] [Related]
19. Barriers to drug discovery and development for Alzheimer disease.
Fillit HM; O'Connell AW; Brown WM; Altstiel LD; Anand R; Collins K; Ferris SH; Khachaturian ZS; Kinoshita J; Van Eldik L; Dewey CF
Alzheimer Dis Assoc Disord; 2002; 16 Suppl 1():S1-8. PubMed ID: 12070355
[TBL] [Abstract][Full Text] [Related]
20. Bridging the gap: facilities and technologies for development of early stage therapeutic mAb candidates.
Munro TP; Mahler SM; Huang EP; Chin DY; Gray PP
MAbs; 2011; 3(5):440-52. PubMed ID: 21822050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
